PUBLIC CONTRACT · 2025
Aquisição de ECULIZUMAB 300 MG SOL INJ FR 30 ML IV (BEKEMV), abrigo do acordo quadro 2023/491
- Contract value
- €456,960.00
- Signed on
- 18 June 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11730093PUBLISHED SUBJECT
Aquisição de ECULIZUMAB 300 MG SOL INJ FR 30 ML IV (BEKEMV), abrigo do acordo quadro 2023/491
Parties involved
- Place of performance
- Portugal, Braga, Braga
- NUTS region
- PT112 - Cávado
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AMGEN BIOFARMACEUTICA, LDA · Tax ID 502942959
Values and timeline
- Contract price
- €456,960.00
- Procedure base price
- €456,960.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 19 September 2025
- Award date
- 18 June 2025
- Signing date
- 18 June 2025
- Performance period
- 212 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea i) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- 491/2023 - Concurso público internacional para formação do acordo quadro de medicamentos do foro oncológico e imunomoduladores
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7671667
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.